Related references
Note: Only part of the references are listed.Inflammatory cytokines in human pancreatic cancer
Rozita Roshani et al.
CANCER LETTERS (2014)
Treatment with Chemotherapy and Dendritic Cells Pulsed with Multiple Wilms' Tumor 1 (WT1)-Specific MHC Class I/II-Restricted Epitopes for Pancreatic Cancer
Shigeo Koido et al.
CLINICAL CANCER RESEARCH (2014)
Prognostic Significance of Interleukin-8 and CD163-Positive Cell-Infiltration in Tumor Tissues in Patients with Oral Squamous Cell Carcinoma
Yohei Fujita et al.
PLOS ONE (2014)
Targeting interleukin-6 in inflammatory autoimmune diseases and cancers
Xin Yao et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study
Hideki Ueno et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Cytokine patterns in patients with cancer: a systematic review
Bodo E. Lippitz
LANCET ONCOLOGY (2013)
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Nuclear factor-kappa B and interleukin-6 related docetaxel resistance in castration-resistant prostate cancer
Jordi Codony-Servat et al.
PROSTATE (2013)
Interleukin-8, a promising predictor for prognosis of pancreatic cancer
Ying Chen et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Current Immunotherapeutic Approaches in Pancreatic Cancer
Shigeo Koido et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2011)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Advanced pancreatic carcinoma: current treatment and future challenges
Anastasios Stathis et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Dendritic cell vaccination and immune monitoring
E. H. J. G. Aarntzen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Interleukin-8 increases vascular endothelial growth factor and neuropilin expression and stimulates ERK activation in human pancreatic cancer
Min Li et al.
CANCER SCIENCE (2008)
Cytokine expression profile in human pancreatic carcinoma cells and in surgical specimens: implications for survival
G Bellone et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Share Paper
